$1.16
-0.11 (-8.66%)
HCAT News30 articles
SCHD ETF Boosts Healthcare in Rebalance as Dividend Fund Inflows Surge
The Schwab U.S. Dividend Equity ETF (SCHD) increased its healthcare allocation to 18.5% during its yearly portfolio update, adding Abbott Laboratories and UnitedHealth Group. The fund gathered nearly $4 billion in the first quarter as investors poured a total of $24.1 billion into U.S. dividend-focused funds, marking the strongest quarterly start since 2022.
UnitedHealth Shares Drop Ahead of Q1 Report, Sector Under Pressure
UnitedHealth Group shares declined sharply Friday, extending weekly losses as the market anticipates first-quarter results. The health insurance sector broadly retreated.
Welltower Retreats as Rate Hike Jitters Rattle Healthcare REITs
Shares of healthcare real estate investment trust Welltower declined sharply as rising bond yields and shifting Federal Reserve expectations pressured the sector. The stock closed significantly below a recent peak.
Bradesco Shareholders Approve Major Capital Boost Ahead of Healthcare Vote
Banco Bradesco secured shareholder approval for a 6.67 billion reais capital increase, raising its stock capital to 93.77 billion reais. The move precedes a crucial March 31 vote on restructuring its healthcare operations.
Bradesco Shareholders Approve Capital Increase, Eye Healthcare Restructuring
Banco Bradesco secured shareholder approval for a R$6.67 billion capital boost through reserve capitalization, leaving its ADR price unchanged. Investors now await a key March 31 vote on consolidating healthcare assets under Odontoprev.
Amazon Faces Key Week After Service Outage, Healthcare AI Launch
Amazon resolved a significant U.S. shopping outage that contributed to a stock decline, while its AWS unit introduced a new AI platform for healthcare. Market focus shifts to upcoming inflation data.
Bradesco Consolidates Health Assets into $52B Bradsaúde Ahead of March Vote
Banco Bradesco will combine its health and dental assets into a new publicly traded entity named Bradsaúde, targeting R$52 billion in 2025 revenue. The proposal requires shareholder approval on March 31.
Pro Medicus Rebounds 9% as Healthcare Tech Recovers from AI Selloff
Pro Medicus shares jumped over 9% on Friday, rebounding from a brutal selloff triggered by AI concerns. First-half revenue grew 28.4% to A$124.8 million, though it fell short of consensus expectations.
Salesforce Unveils AI Healthcare Agents, Stock Gains Amid Sector Competition
Salesforce introduced six new AI agents for healthcare workflows, with integrations from HealthEx, Verily, and Viz.ai. The company's stock climbed 3.8% as competitors AWS and Google Cloud announced similar healthcare AI platforms.
AWS Launches AI Platform to Automate Healthcare Administrative Tasks
Amazon's cloud division has unveiled Amazon Connect Health, an AI-driven platform aimed at reducing administrative burdens in healthcare by automating tasks like patient verification and clinical documentation. Early adopters report efficiency gains, with Amazon shares rising slightly on the news.
UnitedHealth Slashes Subsidiary Disclosure in SEC Filing
UnitedHealth Group has dramatically reduced the number of subsidiaries disclosed in its annual SEC filing to just 10, down from approximately 3,100 previously, offering investors a narrower view of its corporate structure.
UnitedHealth Files Shelf Registration, Announces Accounting Leadership Change
UnitedHealth Group shares gained 0.5% in after-hours trading to $294.93 after filing a shelf registration for future securities offerings and appointing Dennis Stankiewicz as chief accounting officer.
UnitedHealth Files Shelf Registration, Names New Accounting Chief
UnitedHealth Group shares gained 0.5% in after-hours trading after filing a shelf registration for future securities offerings and appointing a new chief accounting officer. The company's annual report revealed Optum Rx's $188 billion drug spend and a projected Medicare Advantage membership decline for 2026.
UnitedHealth Implements Pay Freeze, Dividend Amid Cost Pressures
UnitedHealth Group has limited employee pay increases to a range of 0% to 2% and initiated layoffs, a move aligning with broader cost-control efforts. The company's board also approved a quarterly cash dividend of $2.21 per share.
GE HealthCare Gains on FDA MRI Clearances; Investor Events Loom
GE HealthCare shares advanced 1.47% to $84.23, marking a fifth consecutive session of gains following FDA 510(k) clearances for two MRI systems and an AI workflow platform. Investor attention turns to upcoming management presentations.
DBS Advances on Healthcare Social Loan, Eyes Bank Earnings
DBS Group Holdings closed higher, announcing a landmark healthcare social loan. Market attention now pivots to Singapore bank earnings due next week.
Ramsay Health Care Proposes Ramsay Santé Spin-Off, Shares Gain
Ramsay Health Care shares advanced after announcing a plan to separate its majority stake in French-listed Ramsay Santé. The proposed spin-off is slated for late 2026, pending approvals.
Sonic Healthcare Surges on Strong Earnings, Dividend Boost
Sonic Healthcare shares rallied close to 10% following robust first-half results, including an 11% profit increase and a higher dividend, while management reaffirmed its annual earnings outlook.
Hinge Health Buyback Signals Undervaluation Amid Mixed Stock Performance
Hinge Health's significant share buyback underscores management confidence despite a valuation gap and mixed short-term stock performance. Pool Inc and Spin Master also present valuation disparities amid shifting market sentiment.
UnitedHealth Rallies Ahead of Key Medicare Decision
UnitedHealth Group shares closed 3.1% higher at $293.19 on Friday, marking a three-day rally. Investors are now focused on the upcoming final 2027 Medicare Advantage rate decision.
Healthcare ETF Rises on Dexcom, Moderna Earnings; Markets Eye Holiday
Healthcare stocks advanced Friday, with the XLV ETF rising 1.1% as Dexcom and Moderna posted strong quarterly results. U.S. markets are closed Monday for the Presidents Day holiday.
Walmart Earnings Loom as Investors Gauge Consumer Health
Walmart shares approach $134 as the retail giant prepares to report quarterly earnings, offering a crucial snapshot of consumer demand ahead of key economic data.
HCA Healthcare Holds Gains After Strong Profit Outlook, $10B Buyback
HCA Healthcare stock maintained after-hours gains after a sharp rally, fueled by an upbeat profit outlook and a massive new buyback authorization. Investors now eye key economic data.
UnitedHealth Gains Amid Market Rout as Medicare Advantage Deadlines Loom
UnitedHealth shares advanced nearly 2% on Thursday, defying a broad market decline, as attention turned to key Medicare Advantage policy deadlines and a profit warning from peer Humana.
Hinge Health Gains on Strong 2026 Revenue Forecast, Despite GAAP Loss
Hinge Health shares advanced in premarket trading following a robust Q4 and an upbeat 2026 revenue outlook. RBC maintained an Outperform rating but trimmed its price target.
Tenet Healthcare Soars on Strong Q4, Upbeat 2026 Profit Forecast
Tenet Healthcare shares surged 16% after posting robust fourth-quarter earnings and raising its 2026 adjusted EBITDA outlook to $4.485–$4.785 billion. The company flagged a potential $250 million headwind from expiring ACA subsidies.
Amazon Shares Retreat as Investors Assess AI Capex and Healthcare Expansion
Amazon stock declined 0.7% Wednesday as markets weighed the company's substantial AI investment plans and a major pharmacy delivery expansion.
UnitedHealth Gains Amid Medicare Rate Uncertainty and ACA Investigations
UnitedHealth shares edged higher as investors monitored upcoming Medicare Advantage payment decisions and a House Republican probe into ACA insurers. The sector traded mixed.
Oscar Health Shares Gain on Upbeat 2026 Forecast Amid Regulatory Scrutiny
Oscar Health's stock advanced in premarket trading after the insurer projected a return to operating profitability by 2026, despite a wider quarterly loss and a new House subpoena over ACA subsidies.
Johnson & Johnson Shares Dip in Extended Trading Amid Healthcare Sector Weakness
Johnson & Johnson stock declined 0.6% in after-hours trading Monday as healthcare stocks underperformed the broader market. The company faces ongoing talc litigation and will present at an industry conference next month.